EU regulator accepts Sanofi/Regeneron's Dupixent product for review

PARIS, Dec 8 (Reuters) - The European Medicines Agency

(EMA), the European Union's health regulator, has accepted for

review the Dupixent product being developed by drugmakers Sanofi

and Regeneron,...

Read more